-
The FOG score detects relevant changes of gait freezing for patients and experts
-
The FOsmetpantotenate Replacement Therapy (FORT) Pivotal Trial: Utilization of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration
-
The Gut Microbiota in a Canadian Parkinson’s Disease Cohort
-
The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy
-
The highly selective 5-HT2A receptor antagonist EMD-281,014 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease
-
The History of Huntington Disease Description in Russia
-
The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch
-
The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews
-
The impact of bilingualism in brain structure and function in early and mild Huntington’s disease
-
The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease
- « Previous Page
- 1
- …
- 157
- 158
- 159
- 160
- 161
- …
- 177
- Next Page »